How does Iran's stem cell export become a protective shield for its economy?
🔹Although the oil trade remains under severe sanctions, Iran's "biotechnology economy" has turned the equation around: products consisting of individual vials produce added value equivalent to tens of thousands of barrels of oil, and due to their biological nature, they are virtually immune to sanctions.
🔹 Iran's rise to 8th place in the world in stem cell production, to 2nd place in the world in the national cord blood banking network, and inclusion among the top 5 countries in the world for eye stem cell transplantation demonstrate a strategic transition from hydrocarbons to biotechnology. This transition ensured foreign exchange stability and economic resilience even in the most challenging geopolitical times. 🔹Today, this deterrence capability has become a geo-economic lever, thanks to Iran's acquisition of the most prestigious international approvals, including EU-GMP and approval from the European Medicines Agency (EMA).
🔹Securing over 250 international licenses, exporting advanced biosimilar medicines to more than 70 countries, and implementing 8 large technology transfer projects in 6 strategic countries have made Iran's health systems dependent on its indigenous biotech innovations. This established Iran's economy as "unbreakable" and effectively dismantled traditional models of economic sanctions and blockades.
tasnimnews.ir/3743276.